» Articles » PMID: 18625954

Effect of Intravitreous Rituximab Injections in Patients with Recurrent Ocular Lesions Associated with Central Nervous System Lymphoma

Overview
Journal Arch Ophthalmol
Specialty Ophthalmology
Date 2008 Jul 16
PMID 18625954
Citations 12
Authors
Affiliations
Soon will be listed here.
Citing Articles

Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives.

Kaburaki T, Taoka K Jpn J Ophthalmol. 2023; 67(4):363-381.

PMID: 37209195 DOI: 10.1007/s10384-023-00997-6.


A comprehensive review of intravitreal immunosuppressants and biologicals used in ophthalmology.

Hasan N, Chawla R, Shaikh N, Kandasamy S, Azad S, Sundar M Ther Adv Ophthalmol. 2022; 14:25158414221097418.

PMID: 35602659 PMC: 9121505. DOI: 10.1177/25158414221097418.


Vitreous and Optic Nerve Infiltration of an Adrenal B Lymphoma.

Galletero Pandelo L, Rodriguez Vidal C, Artaraz J, Martinez-Alday N, Fonollosa A Case Rep Ophthalmol. 2021; 12(3):915-920.

PMID: 34950020 PMC: 8647120. DOI: 10.1159/000520338.


Primary central nervous system lymphoma: essential points in diagnosis and management.

Paydas S Med Oncol. 2017; 34(4):61.

PMID: 28315229 DOI: 10.1007/s12032-017-0920-7.


[Diagnostics and treatment of primary vitreoretinal lymphoma].

Stubiger N, Kakkassery V, Gundlach E, Winterhalter S, Pleyer U Ophthalmologe. 2015; 112(3):223-30.

PMID: 25698590 DOI: 10.1007/s00347-014-3204-z.